ResidualPlaybeta Open the radar

CURE - A Hospital Simulator

Sentinel Games · 2025 · $9.99 · Simulation · deal grade B

Measured on 2026-10-05 12:15 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

  • Estimated net residual revenue: $2.5k to $3.8k per month
  • Opportunity: $4.1k per month at x1.30 dormancy
  • Estimated lifetime owners: 34.1k
  • 88% positive across 1007 reviews · 37.3 reviews/month

Why it's flagged

  • Developer active, last post 0 months ago
  • Store page localized in only 1 language(s)
  • Last discounted 0 months ago, 10 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-08-28; the live figures above take precedence over any numbers in it.

Early-access cooperative hospital management sim where you diagnose and treat patients solo or with friends, optionally battling zombies.

CURE sits in a rare pocket: strong community sentiment (87% positive), steady residual revenue, and developer actively shipping updates post-launch communication. The sim-management-meets-cozy-chaos blend has proven sticky with a 75% still-playing ratio. Risk is real, early access means content incompleteness and stability issues are still cited, but the foundation and player retention suggest a live-service play rather than abandonment. Most realistic play: publishing.

  • Risk: Multiple reports of hard crashes (black screens, system freezes) across different hardware, suggesting unresolved driver or engine compatibility issues that could throttle mainstream adoption if not fixed pre-1.0.
  • Risk: Solo-challenging difficulty and limited customization (player avatars, difficulty knobs, staff hiring) are friction points; without addressing these, growth may plateau among wider casual audiences.
  • Risk: Early-access status means no guaranteed 1.0 launch date; extended pre-release limbo risks buyer confidence and could stall inbound organic discovery.

This case as Markdown · Estimates carry ±30-50% error per title.